Aptevo Therapeutics Inc.
About
What does Aptevo Therapeutics Inc. do?
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of various forms of cancer. They leverage their proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients. The company's pipeline includes clinical candidates for hematologic malignancies like acute myeloid leukemia and preclinical candidates for solid tumors.
What is Aptevo Therapeutics Inc.'s Effective Domain Rating?
StartupHub's Effective Domain Rating for Aptevo Therapeutics Inc. is 50 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 32, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Aptevo Therapeutics Inc. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Aptevo Therapeutics Inc. is 69 out of 100, based on site security posture and privacy practices.
Where is Aptevo Therapeutics Inc. headquartered?
Aptevo Therapeutics Inc. is headquartered in Seattle, United States.
When was Aptevo Therapeutics Inc. founded?
Aptevo Therapeutics Inc. was founded in 2016.
What industry does Aptevo Therapeutics Inc. operate in?
Aptevo Therapeutics Inc. operates in Biotech, MedTech, Drug Discovery, Oncology, Immunotherapy, Clinical Trials.
AI precision medicine company transforming cancer diagnostics and patient outcomes through cutting-edge foundation models and multi-modal data.
Tryal develops eClinical software solutions that streamline and support clinical trial operations for pharmaceutical and biotechnology companies, CROs, and research sites.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
A web portal for precision tracking in performance biology, offering anonymous-first protocol design and immutable versioning.
Peak Peptides provides high-purity, third-party tested research-grade peptides for scientific research and laboratory use.
Olera is a Brazilian biotechnological skincare brand offering high-performance products with native Amazonian ingredients.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 9 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Scan this site yourselfStrength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.
Check any domain freeOur own read on real cross-surface visibility rather than raw backlink authority. A site can carry a high Domain Rating and still be invisible where people actually look, which is what this measures.
Run the eDR checkGoogle PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.
Open in PageSpeed InsightsWhether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.
Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.
No comments yet. Be the first to share your take.